搜尋結果
Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot
Reuters· 59 分鐘前Moderna said that the European Patent Office had decided to maintain the validity of one of the ...
Half of Japan’s Covid-19 experts faced threats, abuse by ‘anti-vaxxers’: survey
South China Morning Post· 16 小時前Other attacks came in “too-many-to-count” phone calls, letters and email messages, Tanaka told ...
Up 3x In A Week, Will Novavax Stock Continue To See Higher Levels?
Forbes· 13 小時前NVAX stock was trading at around $51 in early June 2022, just before the Fed started increasing ...
London Measles Outbreak Reported Cases Continue To Rise In U.K.
Forbes· 13 小時前Parents in England have been urged to vaccinate their children as the measles virus continues ...